- Record: found
- Abstract: not found
- Article: not found
Inhaled Beta-2 Agonist Salbutamol for the Treatment of Transient Tachypnea of the Newborn
September 2011
September 2011
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To evaluate the efficacy of inhaled salbutamol, a beta-2 adrenergic agonist, for the
treatment of transient tachypnea of the newborn (TTN) and to determine whether inhaled
salbutamol is safe in newborn infants.